Abstract

BackgroundMany Type 2 Diabetes Mellitus (T2DM) patients refuse insulin therapy even when they require this modality of treatment. However, some eventually accept insulin. This study aimed to explore the T2DM patients’ reasons for accepting insulin therapy and their initial barriers to use insulin.MethodsThis qualitative study interviewed twenty-one T2DM patients at a primary care clinic who had been on insulin for more than a year through three in-depth interviews and three focus group discussions. A semi structured interview protocol was used and the sessions were audio-recorded. Subsequently, thematic analysis was conducted to identify major themes.ResultsThe participants’ acceptance of insulin was influenced by their concerns and beliefs about diabetes and insulin. Concerns about complications of poorly controlled diabetes and side effects of other treatment regime had resulted in insulin acceptance among the participants. They also had a strong belief in insulin benefits and effectiveness. These concerns and beliefs were the results of having good knowledge about the diabetes and insulin, experiential learning, as well as doctors’ practical and emotional support that helped them to accept insulin therapy and become efficient in self-care management. These factors also allayed their negative concerns and beliefs towards diabetes and insulin, which were their barriers for insulin acceptance as it caused fear to use insulin. These negative concerns were related to injection (self-injection, needle phobia, injection pain), and insulin use (inconvenience, embarrassment, lifestyle restriction, negative social stigma, and poor self-efficacy), whereas the negative beliefs were 'insulin could cause organ damage’, 'their diabetes was not serious enough’, 'insulin is for life-long’, and 'insulin is for more severe disease only’.ConclusionsExploring patients’ concerns and beliefs about diabetes and insulin is crucial to assist physicians in delivering patient-centered care. By understanding this, physicians could address their concerns with aim to modify their patients’ misconceptions towards insulin therapy. In addition, continuous educations as well as practical and emotional support from others were found to be valuable for insulin acceptance.Trial registrationUniversiti Kebangsaan Malaysia FF-214-2009.

Highlights

  • Many Type 2 Diabetes Mellitus (T2DM) patients refuse insulin therapy even when they require this modality of treatment

  • There are many factors influencing delayed insulin initiation including those caused by healthcare providers and its system, as well as the patients themselves [6,7,8]

  • This study aimed to explore factors that influence T2DM patients in Malaysia to accept insulin. Their barriers towards insulin use which they experienced prior insulin initiation was explored. This qualitative study involved twenty-one T2DM patients who had been on insulin for one year or more (Table 1)

Read more

Summary

Introduction

Many Type 2 Diabetes Mellitus (T2DM) patients refuse insulin therapy even when they require this modality of treatment. This study aimed to explore the T2DM patients’ reasons for accepting insulin therapy and their initial barriers to use insulin. Use of insulin in the management of poorly controlled diabetes has been recommended to prevent and reduce the long-term diabetes complications [1,2]. It reduces patients’ exposure to prolonged hyperglycemia, which increases risks of diabetes-related complications [3]. There are many factors influencing delayed insulin initiation including those caused by healthcare providers and its system, as well as the patients themselves [6,7,8]. One of the main barriers is psychological insulin resistance (PIR), defined as psychological opposition towards insulin use, among patients and healthcare providers [7,9,10]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call